| Literature DB >> 36000431 |
Moses Kachama Nyongesa1, Eva Mwangome2, Paul Mwangi2, Carophine Nasambu2, Judy Wanjiru Mbuthia3, Hans M Koot4, Pim Cuijpers4, Charles R J C Newton5, Amina Abubakar5.
Abstract
BACKGROUND: Problem Management Plus (PM+) is a psychological intervention that seeks to address common mental disorders among individuals exposed to adversity. Thus far, the potential for delivering PM+ by mobile phones has not been evaluated. AIMS: To adapt PM+ for telephone delivery (ten weekly sessions of about 45 min each) and preliminarily evaluate its acceptability and feasibility with young people living with HIV (YLWH) in coastal Kenya.Entities:
Keywords: Common mental disorders; HIV infections; Problem Management Plus; acceptability and feasibility; young people
Year: 2022 PMID: 36000431 PMCID: PMC9438483 DOI: 10.1192/bjo.2022.564
Source DB: PubMed Journal: BJPsych Open ISSN: 2056-4724
Fig. 1PM+ adaptation and preliminary implementation process. Workshop participants were stakeholders in HIV/mental health from Kilifi and Mombasa Counties. *These young people were identified from similar peer groupings at the HIV clinics to avoid accidental disclosure. #These young people were identified and recruited from a larger cross-sectional study that was ongoing at that time recruiting from the HIV clinics in Kilifi and Mombasa Counties.[23] FGD, focus group discussion; HCP, healthcare provider at the HIV clinic; PM+, Problem Management Plus; YLWH, young person living with HIV (aged 18–24 years).
Fig. 2Participant flowchart. PM+, Problem Management Plus.
Participant characteristics
| Characteristic | Qualitative aspect | Quantitative aspect | ||||
|---|---|---|---|---|---|---|
| Workshop participant, | Key informants, | Focus group participants, | Intervention arm, | Waitlist arm, | ||
| Study site | ||||||
| Kilifi | 11 | 3 | 13 | 17 (48.6) | 10 (28.6) | 0.086 |
| Mombasa | 3 | 0 | 0 | 18 (51.4) | 25 (71.4) | |
| Gender | ||||||
| Male | 5 | 0 | 6 | 13 (37.1) | 11 (31.4) | 0.615 |
| Female | 9 | 3 | 8 | 22 (62.9) | 24 (68.6) | |
| Age (years) | ||||||
| Range | 29–58 | 36–50 | 18–24 | 18–24 | 18–24 | |
| Mean (s.d.) | – | – | – | 21.1 (2.4) | 21.4 (1.8) | 0.574 |
| Education level | ||||||
| Primary | 0 | 0 | 3 | 18 (51.4) | 12 (34.2) | |
| Secondary | 0 | 0 | 8 | 12 (34.3) | 15 (42.9) | |
| College/university degree | 10 | 3 | 3 | 5 (14.3) | 8 (22.9) | 0.329 |
| Postgraduate degree (Masters, PhD) | 4 | 0 | 0 | Not applicable | Not applicable | |
| Overall working experience | ||||||
| <5 years | 4 | 0 | Not applicable | Not applicable | Not applicable | |
| 5–10 years | 2 | 1 | Not applicable | Not applicable | Not applicable | |
| >10 years | 8 | 2 | Not applicable | Not applicable | Not applicable | |
| Viral load | ||||||
| ≤1000 copies/mL | Not applicable | Not applicable | Not applicable | 24 (68.6) | 20 (57.1) | 0.322 |
| >1000 copies/mL | Not applicable | Not applicable | Not applicable | 11 (31.4) | 15 (42.9) | |
| HIV clinical staging | ||||||
| Stages 1 and 2 | Not applicable | Not applicable | Not applicable | 29 (82.9) | 30 (85.7) | 0.743 |
| Stages 3 and 4 | Not applicable | Not applicable | Not applicable | 6 (17.1) | 5 (14.3) | |
| ART duration | ||||||
| >5 years | Not applicable | Not applicable | Not applicable | 22 (62.9) | 21 (60.0) | 0.213 |
| 1–5 years | Not applicable | Not applicable | Not applicable | 7 (20.0) | 12 (34.3) | |
| <1 year | Not applicable | Not applicable | Not applicable | 6 (17.1) | 2 (5.7) | |
| BMI, kg/m2 | Not applicable | Not applicable | Not applicable | 19.7 (2.0) | 21.0 (4.6) | 0.149 |
| Asset index score | Not applicable | Not applicable | Not applicable | 2.2 (1.8) | 2.5 (1.5) | 0.439 |
All data are in numbers (%) except age, which is a range or mean (s.d.). ART, antiretroviral therapy; BMI, body mass index.
Score range 0–7, higher scores indicate better socioeconomic status.
Key themes and select illustrative quotes from the qualitative interviews on contextual appropriateness of PM+ adaptations
| Theme | Illustrative quote |
|---|---|
| Cultural appropriateness of the proposed PM+ intervention strategies, and accompanying materials | ‘Does it interfere with our culture in any way? I don't think. I think they [strategies] are appropriate.’ (Workshop participant, female, 36 years old) |
| Using mobile phones to deliver the adapted PM+ | ‘To me I will say it would enhance a lot of confidentiality in the sense that I am talking through the phone and I will decide where.’ |
| Use of trained lay helpers | ‘To me, if somebody is trained and they have that knowledge and they have the competence, I think to me it's much okay.’ |
| Delivering ten weekly intervention sessions of the adapted PM+ | ‘I think for me the sessions that I have seen with other interventions, ten weekly sessions are usually a good standard. I think for me it is adequate.’ |
| Delivering the adapted PM+ for 45 min per session | ‘If it is done objectively, 45 min are enough because now I am thinking a scenario whereby, we are talking and there are issues to address, even it won't be enough.’ |
PM+, Problem Management Plus.
None of the participants across the stakeholder workshop, key informant interviews and focus group discussions raised concern with the use of lay helpers for intervention delivery.
Mean scores on outcome measure in intervention versus waitlist groups at baseline, endline and follow-up time points
| Intervention arm | Waitlist arm | ||
|---|---|---|---|
| Primary outcomes | |||
| Depressive symptom scores (PHQ-9) | |||
| Baseline | 9.3 (8.2–10.4); | 10.0 (8.8–11.3); | 0.372 |
| Endline (12 weeks) | 4.9 (3.4–6.4); | 8.9 (7.0–10.7); | |
| Follow-up (24 weeks) | 5.6 (3.5–7.6); | 8.2 (6.5–10.0); | |
| Anxiety symptom scores (GAD-7) | |||
| Baseline | 7.1 (6.0–8.2); | 7.8 (6.8–8.8); | 0.336 |
| Endline (12 weeks) | 4.6 (3.1–6.1); | 7.0 (5.4–8.6); | |
| Follow-up (24 weeks) | 4.9 (3.3–6.4); | 6.5 (5.1–7.9); | 0.116 |
| Secondary outcomes | |||
| Perceived social support scores (SPS) | |||
| Baseline | 73.7 (69.9–77.6); | 69.9 (65.5–73.7); | 0.135 |
| Endline (12 weeks) | 76.3 (72.2–80.4); | 71.1 (66.4–75.9); | 0.103 |
| Follow-up (24 weeks) | 77.0 (71.6–82.4); | 72.5 (67.9–77.1); | 0.194 |
| Quality of life scores (FAHI) | |||
| Baseline | 126.8 (117.2–136.4); | 116.3 (107.0–125.7); | 0.117 |
| Endline (12 weeks) | 137.5 (128.6–146.4); | 123.0 (113.7–132.2); | |
| Follow-up (24 weeks) | 137.8 (127.1–148.5); | 124.2 (113.3–135.1); | 0.076 |
Statistically significant between-group differences are given in bold. For the PHQ-9 and GAD-7, lower scores indicate better mental well-being; for the SPS and FAHI, higher scores indicate better perceived social support and quality of life. PHQ-9, Patient Health Questionnaire (nine items); GAD-7, Generalised Anxiety Disorder Scale (seven items); SPS, Social Provisions Scale (24 items); FAHI, Functional Assessment of HIV Infection questionnaire (44 items).